Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 3

NCT06134804

A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza V…

The purpose of this study is to show that high-dose quadrivalent seasonal influenza vaccine (HD QIV) given together with 9-valent extraintestinal pathogenic Esc…

United States959 participantsStarted 2023-10-24

Treatment: ExPEC9V, Placebo

CompletedPhase 3

NCT04899336

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of…

The purpose of this study is to demonstrate the efficacy of 9-valent extraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared to placebo in the pr…

United States17,935 participantsStarted 2021-06-30

Treatment: ExPEC9V, Placebo